Atea Pharmaceuticals, Inc. 10-Q filing
Filed 2026-05-12 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-219678
- Form type
- 10-Q
- CIK
- 0001593899
- Primary document
- https://www.sec.gov/Archives/edgar/data/1593899/000119312526219678/avir-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Atea Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-48.0M | - | - |
| Net Income | $-45.4M | - | - |
| Eps Basic | -0.57 | - | - |
| Eps Diluted | -0.57 | - | - |
| Cash And Equivalents | $79.3M | - | - |
| Total Assets | $267.1M | - | - |
| Shareholders Equity | $233.7M | - | - |
| Operating Cash Flow | $-46.4M | - | - |